Coya Therapeutics, Inc. (COYA)

NASDAQ: COYA · IEX Real-Time Price · USD

7.00

+0.01 (0.14%)

At close: Jul 19, 2024, 4:30 PM

6.99

-0.01 (-0.14%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Coya Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022
Market Capitalization	107	74	46
Market Cap Growth	264.96%	62.06%	-
Enterprise Value	71	42	53
PE Ratio	-	-9.30	-3.74
PS Ratio	17.38	12.38	-
PB Ratio	3.29	2.09	-5.46
P/FCF Ratio	-27.85	-6.64	-6.34
P/OCF Ratio	-27.85	-6.64	-6.34
EV/Sales Ratio	11.51	6.95	-
EV/EBITDA Ratio	-11.34	-5.76	-4.33
EV/EBIT Ratio	-11.30	-5.74	-4.32
EV/FCF Ratio	-20.91	-3.73	-7.31
Debt / Equity Ratio	-	-	-1.54
Debt / EBITDA Ratio	-	-	-1.06
Debt / FCF Ratio	-	-	-1.79
Quick Ratio	8.33	7.94	1.55
Current Ratio	8.64	8.15	1.88
Asset Turnover	0.23	0.28	0
Return on Equity (ROE)	-45.10%	-42.50%	515.60%
Return on Assets (ROA)	-39.20%	-37.60%	-185.70%
Return on Capital (ROIC)	-32.37%	-22.18%	-214.61%
Earnings Yield	-9.67%	-10.75%	-26.70%
FCF Yield	-4.86%	-15.05%	-15.79%
Buyback Yield / Dilution	-48.71%	-292.40%	-0.01%
Total Shareholder Return	-48.71%	-292.40%	-0.01%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).